Nvpanon-D Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed for the management of gastrointestinal disorders characterized by acid reflux, delayed gastric emptying, and associated symptoms. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, thereby alleviating nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, improving patient compliance and symptom control. Nvpanon-D Capsule SR is indicated for patients requiring combined prokinetic and acid suppression therapy. It should be used under medical supervision, considering contraindications such as hypersensitivity to components and caution in patients with cardiac arrhythmias or hepatic impairment. Adverse effects may include headache, dry mouth, abdominal cramps, and rare extrapyramidal symptoms. This combination therapy offers a synergistic approach to managing complex upper gastrointestinal conditions, optimizing symptom relief and mucosal healing.

Dosage & How to Use